Ewout Fanoy
About
In The Last Decade
Ewout Fanoy
51 papers receiving 742 citations
Peers
Comparison fields: 5 of 96
- Infectious Diseases 389
- Epidemiology 349
- Health 173
- Modeling and Simulation 92
- Public Health, Environmental and Occupational Health 90
Countries citing papers authored by Ewout Fanoy
This map shows the geographic impact of Ewout Fanoy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ewout Fanoy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ewout Fanoy more than expected).
Fields of papers citing papers by Ewout Fanoy
This network shows the impact of papers produced by Ewout Fanoy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ewout Fanoy. The network helps show where Ewout Fanoy may publish in the future.
Co-authorship network of co-authors of Ewout Fanoy
This figure shows the co-authorship network connecting the top 25 collaborators of Ewout Fanoy. A scholar is included among the top collaborators of Ewout Fanoy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ewout Fanoy. Ewout Fanoy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 2 | |
| 3 | 9 | |
| 4 | 1 | |
| 5 | From more testing to smart testing:data-guided SARS-CoV-2 testing choices, the Netherlands, May to September 2020 | 7 |
| 6 | 4 | |
| 7 | 26 | |
| 8 | 7 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | 5 | |
| 12 | Familiarity of general practitioners with Q fever decreases hospitalisation risk. | 2 |
| 13 | 10 | |
| 14 | 17 | |
| 15 | Syndroomsurveillance: een vinger aan de pols van de volksgezondheid. | 2 |
| 16 | [Pre-exposure prophylaxis for the prevention of sexual HIV transmission; new preventative strategy using tenofovir/emtricitabine]. | 1 |
| 17 | 20 | |
| 18 | 3 | |
| 19 | 59 | |
| 20 | 23 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.